Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban dosing regimens for thrombosis prevention during stent-assisted coil embolization of ruptured intracranial aneurysms
ChiCTR2000031383Phase 4Recruiting
- Sponsor
- Gansu Provincial People's Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in brain aneurysm (IA) (2 arms), sponsored by Gansu Provincial People's Hospital. Primary endpoint: Incidence of cerebral infarction. Started Sep 2020; status: recruiting.
02
Drugs
tirofiban
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on ChiCTR2000031383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031383.